LifeArc’s Post

DigitalHealth.London Accelerator Cohort Seven Showcase – Kidney Beam – DigitalHealth.London - DigitalHealth.London #DigitalHealthLondonAcceleratorCohortSevenShowcase - #KidneyBeam The blog post highlights the showcase of Kidney Beam, a digital health solution, as part of the Digital Health London Accelerator Cohort Seven. Kidney Beam aims to revolutionize kidney care through innovative technology. #ProblemStatement The blog post discusses the challenges faced in kidney care, including the need for better patient monitoring and management tools. Kidney Beam addresses these challenges by providing a platform for remote monitoring and personalized care plans. #Solution Kidney Beam offers a comprehensive solution for kidney care, including remote monitoring, data analytics, and personalized care plans. The platform enables healthcare providers to track patient progress and make informed decisions. #Benefits The blog ai.mediformatica.com #london #digitalhealthlondon #kidneybeam #kidneydisease #platform #accelerator #digitalhealthlondonaccelerator #programme #chronickidneydisease #patients #education #acceleratorprogramme #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/4eM6mNW)

Happy to share our latest article on the impact of Faecal Incontinence (FI) on patients' lives and their preferred treatment outcomes. Our study highlights the huge impact FI can have on someones life, and how FI affects not only physical health, but also psychological and social wellbeing, often leading to feelings of fear and insecurity. The systematic review we published last month showed that we as researchers and physicians tend to focus on physical outcomes, whereas patients in this study emphasized the importance of reclaiming normalcy and independence rather than only focusing on symptom reduction. A huge thank you to all the patients who were willing to share their experiences. And thank you to all the authors: Daniel Keszthelyi, Stephanie Breukink, Merel Kimman https://lnkd.in/eg9qGHGx The insights shared by participants in this study, combined with the outcomes identified in our systematic review, Delphi rounds, and consensus meeting with patients and healthcare professionals/researchers, have provided invaluable input for the Faecal Incontinence Core Outcome Set (to be published). 📃

This linked article from Wendy Powell is great guide for anyone wanting to understand more about healthcare commissioning (buying). Obviously it applies to MUTU System (a tool to help women manage their perinatal health) but could be read in a broader context too and especially women’s health technology. If you (innovators) understand the challenges, you can better find ways to overcome them. And if you are looking for advisors who understand the challenges, look no further than Mills & Reeve | Health and care 💁🏼♀️ Thanks for sharing Wendy #HealthTech #WomensHealthTech #FemTech #NHS #DigitalHealth

If you are concerned about the symptoms of Long COVID and how it might affect you, please check out Biocode Technologies.

🎉It's great to see the producers of The Good Doctor adding a Long COVID plotline to S6E18. We see stories like this in the real world every day: high-functioning individuals unable to work, think, move. In this episode, the patient gets no answers or help, which is the case for most of the 100 million+ people struggling with this condition. Why is this? ❌ Currently, there is no diagnostic test for Long COVID. Available clinical tests frequently show no abnormalities, leading to the misconception that there is nothing wrong with these individuals. 🌟 Biocode Technologies is commercialising the first blood test that produces actionable results for Long COVID patients. How? 🔬 Biocode was involved in early research, done by Resia Pretorius and her team at Stellenbosch University, that showed most Long COVID patients have persistent, small clots circulating in their blood. These Microclots may impair blood flow and exacerbate endothelial damage, leading to vascular dysfunction and impaired oxygen delivery to various tissues and organs. This can cause a range of symptoms, including fatigue, cognitive impairment, shortness of breath, chronic pain, post-exertional malaise, and more. 🎉 Even in the early stages of commercialisation, our novel microclot test has played a life-changing role in the lives of many patients with unexplained Long COVID symptoms by providing: ✅ Actionable results ✅ Validation of patient experience ✅ A tangible path to better health Many Long COVID patients treated for clotting experience significant symptom relief or improvement. 🌎 We are working hard to standardise and validate this test for global roll-out. Next time a Long COVID plotline is created, the resolution won't just be a med-drama style monologue about how the patient should learn to accept their fate.

Henry Ford Health has joined the Uncover CKD – Care Collective, a strategic partnership between Premier, AstraZeneca and leading U.S. health systems to address undiagnosed and rising rates of chronic kidney disease (CKD). This collaboration was conceived through Henry Ford Innovations’ ongoing relationship with both partners. The initiative’s goals are to: ·        Identify patients with undiagnosed CKD ·        Raise awareness of undiagnosed CKD among health care professionals ·        Educate and support health systems that want to improve or develop and implement their strategies for CKD diagnosis, treatment and management. An estimated 1 in 7 U.S. adults have CKD, and of these adult patients, 90 percent do not know they have CKD. Black Americans are more than 3 times as likely, and Latinos are 1.3 times more likely, to have kidney failure compared to White Americans. Among CKD patients, the cost of preventable hospitalizations is $79 million. Through the Collective, we are focused on reducing health disparities by co-designing solutions to raise awareness and advance the prevention, detection and treatment of undiagnosed CKD in marginalized and underrepresented groups. We are doing this using scalable solutions, including provider and patient education, real-world data analyses, AI-enabled clinical decision support (CDS) technology and new CKD resources. “We are committed to advancing health equity – addressing social drivers of health and increasing and measuring the delivery of equitable care,” said Denise White-Perkins, MD, PhD, Chair, Henry Ford Department of Family Medicine and Director, Healthcare Equity Initiatives, Office of System Diversity Equity and Inclusion. “Through real-world, data-driven research and solutions co-designed with health systems and life sciences partners, the CKD Care Collective is enabling us to enhance clinical outcomes and financial sustainability, and improve the overall health for all of our patient populations.”

Fountain Life is leveraging advanced diagnostics and personalized treatment plans to optimize health and prevent disease. 🦠 🚀 → Founded by Peter H. Diamandis, Robert Hariri, MD, PhD, and Tony Robbins, Fountain Life is dedicated to extending the healthy lifespan of individuals through cutting-edge medical technology and proactive health management. Founders' Vision: - As a co-founder, Dr. Peter Diamandis is a renowned entrepreneur and futurist known for his work in space exploration and longevity. His vision for Fountain Life is to harness the power of exponential technologies to revolutionize healthcare and extend human lifespan. - Co-founder Dr. Robert Hariri is a surgeon, biomedical scientist, and entrepreneur with extensive experience in regenerative medicine. His vision for Fountain Life is to integrate advanced cellular therapies and regenerative medicine into mainstream healthcare, providing patients with cutting-edge treatments that promote healing and longevity. - As a co-founder, Tony Robbins is a world-renowned life coach, author, and philanthropist. His vision for Fountain Life is to empower individuals to take control of their health and well-being through personalized healthcare solutions. Fountain Life's Mission: - Fountain Life's mission is to revolutionize healthcare by focusing on prevention rather than treatment. The company offers comprehensive health assessments, advanced diagnostics, and personalized treatment plans designed to optimize health and prevent disease. - Fountain Life provides personalized treatment plans based on each individual's unique health profile. These plans include advanced diagnostics, cellular therapies, and lifestyle recommendations to help individuals achieve their health goals. Fascinating Facts: - Fountain Life's innovative healthcare model combines advanced diagnostics with personalized treatment plans to provide a holistic approach to health and wellness. - Fountain Life offers comprehensive health assessments that include blood tests, genetic testing, and other advanced diagnostics to provide a detailed picture of an individual's health. - Fountain Life leverages cutting-edge technology, including artificial intelligence and machine learning, to analyze health data and provide actionable insights. - Fountain Life has established centers in various locations, including the United States and Australia, providing access to advanced healthcare solutions for individuals around the world. With its innovative approach to preventative medicine, personalized treatment plans, and commitment to patient care, Fountain Life continues to set new standards in the healthcare industry. #FountainLife #PreventativeMedicine #HealthcareInnovation #PersonalizedHealthcare #Longevity *** Enjoy this? Share it with your network and follow me Vaibhav Sharma for more in future!   I write about interesting businesses, entrepreneurs, and high performance. Join my inner circle here: https://lnkd.in/gZKZ_Zdb

#digital #health #funding In-home social care services and care coordination startup Accompany Health grabs $56M Cohere Health raises $50M to streamline and automate prior authorizations Avation Medical inks $22M for its wearable to treat urinary incontinence ArteraAI lands $20M for its AI-powered biomarkers for personalized prostate cancer treatment Foodsmart, a Rock Health port co, picks up $10M for its food-as-medicine telenutrition solution CARPL - Radiology AI Platform, a platform enabling radiologists to integrate AI into their workflows, collects $6M Valendo Health, an endocrinology practice management solution, secures $4M Pediatric monitoring, sleep, and wellness provider Harbor plucks $3.7M Aster seeds $2.4M for its practice management software for women+ health-focused clinics #digitalhealth #startups

Parkinson's disease is a complex condition that have a strong impact not only on patients, but also on neurologists and caregivers. As we work to improve the lives of those affected by Parkinson's disease, it's important to address the criticalities and unmet needs of all figures involved. One of the main pain points is the sharing of updated clinical data between patients and doctors, which can be a challenge due to the limited availability of integrated data collection systems focused on Parkinson's disease . Additionally, frequent in-presence medical appointments  are often necessary, which can represent a particular discomfort for frail patients and their caregivers. At BRAIN INNOVATIONS, we are developing a digital solution able to solve these challenges, offering patients the possibility to collect data on their symptoms directly from their smartphone📱 or smartwatch⌚ and to share these with healthcare professionals through a dedicated web app interface 💻. Moreover, the solution, developed in collaboration with patients in a real clinical setting, will also enable remote communication and video-conferencing through a telemedicine platform. Stay tuned for updates 🚀!

Health care innovation is accelerating even more rapidly now with many exciting developments in research and implementation of cutting-edge treatments, including cancer therapies and transplantation advances; digital technologies that connect patients and providers to monitor medications and vital signs; and technology to better manage chronic conditions using data analytics that support clinical decision-making and promote preventive care. There is more on the horizon as science advances innovation. #healthinnovation #ama #acos #valuebasedcare https://lnkd.in/gDZTF5qh